Artiva Biotherapeutics, Inc. (ARTV)

CIK 1817241 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Artiva Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001193125-26-389514
Sep 11, 202640001193125-26-389512
Sep 11, 20268-K0001193125-26-389308
Sep 11, 2026S-80001193125-26-389428
Sep 11, 202640001193125-26-389510
Sep 11, 202640001193125-26-389511
Sep 9, 202640001193125-26-386431
Sep 8, 202640001193125-26-385418
Sep 8, 202640001193125-26-385409
Sep 8, 202640001231919-26-001152
Sep 8, 20261440001950047-26-009217
Sep 8, 202640001193125-26-385412
Sep 8, 202640001193125-26-385416
Sep 8, 202640001193125-26-385414
Sep 8, 202640001193125-26-385419
Sep 4, 202640001193125-26-383625
Sep 4, 202640001193125-26-383619
Sep 4, 202640001193125-26-383618
Sep 4, 202640001193125-26-383621
Aug 31, 202640001193125-26-377207
Aug 27, 20261440001950047-26-008761
Aug 19, 202640001193125-26-357383
Aug 18, 20261440001950047-26-008347
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000930
Aug 14, 2026EFFECT9999999995-26-002667